BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 29087473)

  • 21. Addressing the role of 11β-hydroxysteroid dehydrogenase type 1 in the development of polycystic ovary syndrome and the putative therapeutic effects of its selective inhibition in a preclinical model.
    Li X; Hu S; Zhu Q; Yao G; Yao J; Li J; Wang Y; Ding Y; Qi J; Xu R; Zhao H; Zhu Z; Du Y; Sun K; Sun Y
    Metabolism; 2021 Jun; 119():154749. PubMed ID: 33722534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperglycemia-activated 11β-hydroxysteroid dehydrogenase type 1 increases endoplasmic reticulum stress and skin barrier dysfunction.
    Lee YB; Hwang HJ; Kim E; Lim SH; Chung CH; Choi EH
    Sci Rep; 2023 Jun; 13(1):9206. PubMed ID: 37280272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantification of 11β-hydroxysteroid dehydrogenase 1 kinetics and pharmacodynamic effects of inhibitors in brain using mass spectrometry imaging and stable-isotope tracers in mice.
    Cobice DF; Livingstone DEW; McBride A; MacKay CL; Walker BR; Webster SP; Andrew R
    Biochem Pharmacol; 2018 Feb; 148():88-99. PubMed ID: 29248595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 lowers intraocular pressure in patients with ocular hypertension.
    Rauz S; Cheung CM; Wood PJ; Coca-Prados M; Walker EA; Murray PI; Stewart PM
    QJM; 2003 Jul; 96(7):481-90. PubMed ID: 12881590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time of the day for 11beta-HSD1 inhibition plays a role in improving glucose homeostasis in DIO mice.
    Véniant MM; Hale C; Komorowski R; Chen MM; St Jean DJ; Fotsch C; Wang M
    Diabetes Obes Metab; 2009 Feb; 11(2):109-17. PubMed ID: 18479468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 11beta-hydroxysteroid dehydrogenase type 1 inhibitors as promising therapeutic drugs for diabetes: status and development.
    Ge R; Huang Y; Liang G; Li X
    Curr Med Chem; 2010; 17(5):412-22. PubMed ID: 20015040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 11beta-Hydroxysteroid dehydrogenase type 1 regulates insulin and glucagon secretion in pancreatic islets.
    Swali A; Walker EA; Lavery GG; Tomlinson JW; Stewart PM
    Diabetologia; 2008 Nov; 51(11):2003-11. PubMed ID: 18779947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 11β-Hydroxysteroid dehydrogenase type 1 selective inhibitor BVT.2733 protects osteoblasts against endogenous glucocorticoid induced dysfunction.
    Wu L; Qi H; Zhong Y; Lv S; Yu J; Liu J; Wang L; Bi J; Kong X; Di W; Zha J; Liu F; Ding G
    Endocr J; 2013; 60(9):1047-58. PubMed ID: 23759754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucocorticoids and 11β-HSD1 are major regulators of intramyocellular protein metabolism.
    Morgan SA; Hassan-Smith ZK; Doig CL; Sherlock M; Stewart PM; Lavery GG
    J Endocrinol; 2016 Jun; 229(3):277-86. PubMed ID: 27048233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of significant metabolic abnormalities in mice with liver-specific disruption of 11β-hydroxysteroid dehydrogenase type 1.
    Lavery GG; Zielinska AE; Gathercole LL; Hughes B; Semjonous N; Guest P; Saqib K; Sherlock M; Reynolds G; Morgan SA; Tomlinson JW; Walker EA; Rabbitt EH; Stewart PM
    Endocrinology; 2012 Jul; 153(7):3236-48. PubMed ID: 22555437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Local amplification of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1 and its role in the inflammatory response.
    Chapman KE; Coutinho A; Gray M; Gilmour JS; Savill JS; Seckl JR
    Ann N Y Acad Sci; 2006 Nov; 1088():265-73. PubMed ID: 17192572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 11-Dehydrocorticosterone causes metabolic syndrome, which is prevented when 11β-HSD1 is knocked out in livers of male mice.
    Harno E; Cottrell EC; Keevil BG; DeSchoolmeester J; Bohlooly-Y M; Andersén H; Turnbull AV; Leighton B; White A
    Endocrinology; 2013 Oct; 154(10):3599-609. PubMed ID: 23832962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Localization, age- and site-dependent expression, and regulation of 11β-hydroxysteroid dehydrogenase type 1 in skin.
    Tiganescu A; Walker EA; Hardy RS; Mayes AE; Stewart PM
    J Invest Dermatol; 2011 Jan; 131(1):30-6. PubMed ID: 20739946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Skin 11β-hydroxysteroid dehydrogenase type 1 enzyme expression regulates burn wound healing and can be targeted to modify scar characteristics.
    Tsai KH; Shi H; Parungao RJ; Naficy S; Ding X; Ding X; Hew JJ; Wang X; Chrzanowski W; Lavery GG; Li Z; Issler-Fisher AC; Chen J; Tan Q; Maitz PK; Cooper MS; Wang Y
    Burns Trauma; 2023; 11():tkac052. PubMed ID: 36694861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local Glucocorticoid Activation by 11β-Hydroxysteroid Dehydrogenase 1 in Keratinocytes: The Role in Hapten-Induced Dermatitis.
    Terao M; Itoi S; Matsumura S; Yang L; Murota H; Katayama I
    Am J Pathol; 2016 Jun; 186(6):1499-510. PubMed ID: 27070821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In obese mice, exercise training increases 11β-HSD1 expression, contributing to glucocorticoid activation and suppression of pulmonary inflammation.
    Du SF; Yu Q; Chuan K; Ye CL; He ZJ; Liu SJ; Zhu XY; Liu YJ
    J Appl Physiol (1985); 2017 Oct; 123(4):717-727. PubMed ID: 28663379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of 11β-HSD1 Expression by Insulin in Skin: Impact for Diabetic Wound Healing.
    Brazel CB; Simon JC; Tuckermann JP; Saalbach A
    J Clin Med; 2020 Nov; 9(12):. PubMed ID: 33260645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitors of 11β-hydroxysteroid dehydrogenase type 1 in antidiabetic therapy.
    Wang M
    Handb Exp Pharmacol; 2011; (203):127-46. PubMed ID: 21484570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression profiles of cortisol-inactivating enzyme, 11β-hydroxysteroid dehydrogenase-2, in human epidermal tumors and its role in keratinocyte proliferation.
    Terao M; Itoi S; Murota H; Katayama I
    Exp Dermatol; 2013 Feb; 22(2):98-101. PubMed ID: 23362866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 11β-HSD1 plays a critical role in trabecular bone loss associated with systemic glucocorticoid therapy.
    Fenton CG; Doig CL; Fareed S; Naylor A; Morrell AP; Addison O; Wehmeyer C; Buckley CD; Cooper MS; Lavery GG; Raza K; Hardy RS
    Arthritis Res Ther; 2019 Aug; 21(1):188. PubMed ID: 31420008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.